Optogenetic Actuators & Sensors Market Worth $584.73 Million By 2026 |Circuit Therapeutics, Inc., Gensight Biologics, AGTC, Prizmatix, Merck KGaA

 

Optogenetics Actuators & Sensors Market

                               Optogenetics Actuators & Sensors Market


Optogenetics Actuators And Sensors Market Growth & Trends

The global optogenetics actuators & sensors market size is expected to reach USD 584.73 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a 1.93% CAGR during the forecast period. Extensive research in the field of neuroscience and ophthalmology is expected to boost market growth in the coming years. Key players are focusing majorly on research activities to study brain functions in various psychiatric and retinal disease states, which is anticipated to drive the sector. Government organizations are providing funds to academic research institutions and individual researchers for advancements in the field of optogenetics. Moreover, various initiatives undertaken by international organizations such as WHO and NIH are anticipated to boost the market growth. Various projects and initiatives initiated in the field of neuroscience are also promoting growth prospects.

In addition, ongoing investigations to improve signal sizes and responses and target specificity of subcellular membranes such as axon terminals, cell bodies, and dendrites in neuroscience are expected to support the growth of the segment. The rise in the incidence of retinal and brain disorders is ultimately increasing the demand for optogenetic actuators and sensors.

Optogenetics Actuators And Sensors Market Report Highlights

Actuators are estimated to account for the largest revenue share owing to their increased usage in investigations related to neuroscience and ophthalmology

• Sensors are anticipated to grow at the fastest rate in the coming years due to technological advancements in optogenetics • Retinal disorders accounted for the largest revenue share owing to higher usage of optogenetic actuators and sensors in disease-oriented studies. The rise in prevalence of various retinal and psychiatric disorders is also anticipated to boost the segment

• North America dominated the market owing to government support, extensive research, local presence of a substantial number of players, and well-established healthcare framework

• Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support

Optogenetics Actuators & Sensors Product Outlook

Actuators

◦ Channelrhodopsin

◦ Halorhodopsin Biochip

◦ Archaerhodopsin

• Sensors

◦ Genetically Encoded Calcium Indicators

◦ Voltage-Sensitive Fluorescent Proteins

◦ pH Sensors

Optogenetics Actuators & Sensors Disease Type Outlook

Retinal Disorders

• Parkinson’s Disease

• Anxiety & Depression

• Autism

• Schizophrenia

Post a Comment

0 Comments